46 results on '"Vos, Maaike J."'
Search Results
2. Impact of timing of antiseizure medication withdrawal on seizure recurrence in glioma patients: a retrospective observational study
3. Study protocol of the GLOW study: maximising treatment options for recurrent glioblastoma patients by whole genome sequencing-based diagnostics—a prospective multicenter cohort study
4. External Validation of the Lung-MolGPA to Predict Survival in Patients Treated with Stereotactic Radiotherapy for Brain Metastases of Non-Small Cell Lung Cancer
5. Advance care planning in glioblastoma patients: development of a disease-specific ACP program
6. Prediagnostic symptoms and signs of adult glioma: the patients’ view
7. Effectiveness of Antiseizure Medication Triple Therapy in Patients With Glioma With Refractory Epilepsy
8. The Effectiveness of Antiepileptic Drug Duotherapies in Patients with Glioma: A Multicenter Observational Cohort Study: A Multicenter Observational Cohort Study
9. Effectiveness of Antiseizure Medication Duotherapies in Patients With Glioma
10. Seizure reduction is a prognostic marker in low-grade glioma patients treated with temozolomide
11. Advance care planning (ACP) in glioblastoma patients: Evaluation of a disease-specific ACP program and impact on outcomes
12. Additional file 1 of Study protocol of the GLOW study: maximising treatment options for recurrent glioblastoma patients by whole genome sequencing-based diagnostics—a prospective multicenter cohort study
13. Is the EORTC QLQ‐C30 emotional functioning scale appropriate as an initial screening measure to identify brain tumour patients who may possibly have a mood disorder?
14. Is the EORTC QLQ-C30 emotional functioning scale appropriate as an initial screening measure to identify brain tumour patients who may possibly have a mood disorder?
15. Identification of characteristics that determine behavioral and personality changes in adult glioma patients
16. Seizure reduction in a low-grade glioma: more than a beneficial side effect of temozolomide
17. MRI and thallium-201 SPECT in the prediction of survival in glioma
18. First‐line antiepileptic drug treatment in glioma patients with epilepsy: Levetiracetam vs valproic acid
19. Thallium-201 SPECT: the optimal prediction of response in glioma therapy
20. The Impact of the Timing of Health-Related Quality of Life Assessments on the Actual Results in Glioma Patients: A Randomized Prospective Study
21. Radiologic findings in patients treated with boron neutron capture therapy for glioblastoma multiforme within EORTC trial 11961
22. Systematic review of the diagnostic accuracy of 201Tl single photon emission computed tomography in the detection of recurrent glioma
23. Interobserver variability in the semi-quantitative assessment of 201Tl SPECT in cerebral gliomas
24. Thallium-201 Single-Photon Emission Computed Tomography As an Early Predictor of Outcome in Recurrent Glioma
25. Advance care planning in glioblastoma patients: development of a disease-specific ACP program
26. QLIF-11. WITHDRAWAL OF ANTIEPILEPTIC DRUGS IN GLIOMA PATIENTS AFTER LONG-TERM SEIZURE FREEDOM
27. Visual inspection of MR relative cerebral blood volume maps has limited value for distinguishing progression from pseudoprogression in glioblastoma multiforme patients
28. Phase II part of EORTC study 26101: The sequence of bevacizumab and lomustine in patients with first recurrence of a glioblastoma.
29. Seizure reduction is a prognostic marker in low-grade glioma patients treated with temozolomide
30. QOL-27PREVALENCE OF CHANGES IN PERSONALITY AND BEHAVIOR IN ADULT GLIOMA PATIENTS: A SYSTEMATIC REVIEW
31. Prevalence of changes in personality and behavior in adult glioma patients: a systematic review
32. The impact of bevacizumab on health-related quality of life in patients treated for recurrent glioblastoma: Results of the randomised controlled phase 2 BELOB trial
33. Epilepsy with central spikes provoked by fever with a benign disease course
34. The course of neurocognitive functioning in high-grade glioma patients
35. Interobserver variability in the semi-quantitative assessment of tl spect in cerebral gliomas
36. Prevalence of changes in personality and behavior in adult glioma patients: a systematic review.
37. Serum levels of S-100B protein and neuron-specific enolase in glioma patients: a pilot study
38. Withdrawal of antiepileptic drugs in glioma patients after long-term seizure freedom: design of a prospective observational study
39. Seizure reduction in a low-grade glioma: more than a beneficial side effect of temozolomide
40. MRI and thallium-201 SPECT in the prediction of survival in glioma
41. Health-related quality of life of long-term high-grade glioma survivors
42. Thallium-201 SPECT: the optimal prediction of response in glioma therapy
43. Systematic review of the diagnostic accuracy of 201Tl single photon emission computed tomography in the detection of recurrent glioma.
44. First-line antiepileptic drug treatment in glioma patients with epilepsy: Levetiracetam vs valproic acid.
45. The course of neurocognitive functioning in high-grade glioma patients.
46. Serum levels of S-100B protein and neuron-specific enolase in glioma patients: a pilot study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.